» Articles » PMID: 15661400

Human Platelets Exhibit Chemotaxis Using Functional N-formyl Peptide Receptors

Overview
Journal Exp Hematol
Specialty Hematology
Date 2005 Jan 22
PMID 15661400
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Activated platelets participate in inflammatory and microbicidal processes by upregulation of surface selectins, shedding of CD40 ligand, and release of platelet microbicidal proteins and microparticles. Given their myeloid lineage, we hypothesized that platelets express functional N-formyl peptide receptors and respond to the bacterially derived chemotactic peptide N-formyl peptide with gradient-driven chemotaxis.

Methods And Results: Here we show specific binding of N-formyl peptides to the surface of activated platelets. Platelet expression and function of the formyl peptide receptor, FPR, was verified by RT-PCR of the differentiated megakaryocyte MEG-01 cell line, immunoblotting of platelet proteins, and calcium mobilization in platelets with formyl peptide binding. Furthermore, we demonstrate gradient-driven chemotaxis of platelets by video microscopy and transwell migration toward formyl peptides. We also show that endogenous formyl peptides, released by eukaryotic mitochondria from necrotic cells, induce chemotaxis using formyl peptide receptors expressed by thrombin-activated platelets. Conversely, supernatants from cells undergoing apoptotic cell death do not induce platelet chemotaxis. Platelet chemotaxis to formyl peptides was blocked with FPR-specific antibody as well as by pertussis toxin inhibition of the formyl peptide G-coupled receptor.

Conclusion: These data establish a new role for platelets in host defense and suggest reexamination of their active function in microbicidal and other host defense activities.

Citing Articles

Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis.

AlOmar S, Mitchell J, AlZahrani E Thromb J. 2024; 22(1):39.

PMID: 38654303 PMC: 11036777. DOI: 10.1186/s12959-024-00606-7.


Mitochondria: the gatekeepers between metabolism and immunity.

Trinchese G, Cimmino F, Catapano A, Cavaliere G, Mollica M Front Immunol. 2024; 15:1334006.

PMID: 38464536 PMC: 10920337. DOI: 10.3389/fimmu.2024.1334006.


Exploring bias in platelet P2Y signalling: Host defence versus haemostasis.

Pan D, Ladds G, Rahman K, Pitchford S Br J Pharmacol. 2023; 181(4):580-592.

PMID: 37442808 PMC: 10952580. DOI: 10.1111/bph.16191.


Fish Models for Exploring Mitochondrial Dysfunction Affecting Neurodegenerative Disorders.

Otsuka T, Matsui H Int J Mol Sci. 2023; 24(8).

PMID: 37108237 PMC: 10138900. DOI: 10.3390/ijms24087079.


Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation.

Zhang Q, Ain Q, Schulz C, Pircher J Front Immunol. 2023; 14:1151926.

PMID: 37090695 PMC: 10114025. DOI: 10.3389/fimmu.2023.1151926.